0%
0%
0%
0%
0%
About H. LUNDBECK A/S B
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Deborah L. Dunsire
Website
lundbeck.com
Headquarters
Valby
Employees
5.45K
Founded
1950
ISIN
DK0061804770
H. Lundbeck A/S engages in the research, development, production and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, North America, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
